Operating Margin of Seres Therapeutics, Inc. from 31 Dec 2016 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Seres Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 30 Sep 2024.
  • Seres Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2024 was -346791%, a 654942% decline year-over-year.
  • Seres Therapeutics, Inc. annual Operating Margin for 2023 was -154%, a 94% increase from 2022.
  • Seres Therapeutics, Inc. annual Operating Margin for 2022 was -2524%, a 5572% decline from 2021.
  • Seres Therapeutics, Inc. annual Operating Margin for 2021 was -44%, a 83% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Seres Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -346791% -346738% -654942% 01 Jul 2024 30 Sep 2024
Q2 2024 -63466% -63403% -100948% 01 Apr 2024 30 Jun 2024
Q1 2024 -125% +3683% +97% 01 Jan 2024 31 Mar 2024
Q4 2023 -154% +2370% +94% 01 Oct 2023 31 Dec 2023
Q3 2023 -53% +1649% +97% 01 Jul 2023 30 Sep 2023
Q2 2023 -63% +10% +14% 01 Apr 2023 30 Jun 2023
Q1 2023 -3809% -3748% -6210% 01 Jan 2023 31 Mar 2023
Q4 2022 -2524% -2480% -5572% 01 Oct 2022 31 Dec 2022
Q3 2022 -1702% -1681% -7918% 01 Jul 2022 30 Sep 2022
Q2 2022 -73% +365% +83% 01 Apr 2022 30 Jun 2022
Q1 2022 -60% +277% +82% 01 Jan 2022 31 Mar 2022
Q4 2021 -44% +221% +83% 01 Oct 2021 31 Dec 2021
Q3 2021 -21% +363% +94% 01 Jul 2021 30 Sep 2021
Q2 2021 -438% -173% -65% 01 Apr 2021 30 Jun 2021
Q1 2021 -338% -148% -78% 01 Jan 2021 31 Mar 2021
Q4 2020 -265% -57% -27% 01 Oct 2020 31 Dec 2020
Q3 2020 -384% -186% -94% 01 Jul 2020 30 Sep 2020
Q2 2020 -265% -64% -32% 01 Apr 2020 30 Jun 2020
Q1 2020 -189% +116% +38% 01 Jan 2020 31 Mar 2020
Q4 2019 -208% +146% +41% 01 Oct 2019 31 Dec 2019
Q3 2019 -198% +326% +62% 01 Jul 2019 30 Sep 2019
Q2 2019 -201% +69% +26% 01 Apr 2019 30 Jun 2019
Q1 2019 -305% -22% -7.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -355% -70% -25% 01 Oct 2018 31 Dec 2018
Q3 2018 -524% -252% -92% 01 Jul 2018 30 Sep 2018
Q2 2018 -270% +179% +40% 01 Apr 2018 30 Jun 2018
Q1 2018 -284% +164% +37% 01 Jan 2018 31 Mar 2018
Q4 2017 -285% +142% +33% 01 Oct 2017 31 Dec 2017
Q3 2017 -272% 01 Jul 2017 30 Sep 2017
Q2 2017 -449% 01 Apr 2017 30 Jun 2017
Q1 2017 -448% 01 Jan 2017 31 Mar 2017
Q4 2016 -427% 01 Oct 2016 31 Dec 2016

Seres Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -154% +2370% +94% 01 Jan 2023 31 Dec 2023
2022 -2524% -2480% -5572% 01 Jan 2022 31 Dec 2022
2021 -44% +221% +83% 01 Jan 2021 31 Dec 2021
2020 -265% -57% -27% 01 Jan 2020 31 Dec 2020
2019 -208% +146% +41% 01 Jan 2019 31 Dec 2019
2018 -355% -70% -25% 01 Jan 2018 31 Dec 2018
2017 -285% +142% +33% 01 Jan 2017 31 Dec 2017
2016 -427% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.